OHSU Knight Cancer Institute
@ohsuknight.bsky.social
190 followers 39 following 310 posts
A leader in cancer research, the OHSU Knight Cancer Institute provides individually-tailored, compassionate care for patients, from diagnosis through survivorship.
Posts Media Videos Starter Packs
Pinned
ohsuknight.bsky.social
Phil and Penny Knight announced today a record-breaking $2 billion gift to the Oregon Health & Science University’s Knight Cancer Institute to transform the future of cancer care and set a new standard globally.

Thank you to Phil and Penny Knight for their incredible generosity.

#GiveCancerHell
White text over a black background; “Give Cancer Hell” An OHSU Knight Cancer Institute logo is placed below. The top text reads:

Cancer is the biggest fight in the history of the world. We will win.
It will be hard. We're built for it.
We care. Every breath. Of every second. Of every day.
Great things come from the most unexpected places.
Look around. We're surrounded by heroes.
This is not a job. This is our life.
Cancer does not discriminate. Neither will we.
Bold moves only.
Cancer doesn't see us coming. We will outlast, and we will outwit it.
This fight is and always will be personal.
"GIVE CANCER HELL." in bold at the bottom.
ohsuknight.bsky.social
Last week, Nike celebrated the Portland Marathon and our local community with one of their signature employee events – Thirst Thursday.

They welcomed the OHSU Foundation, #DBFreestyle, and other nonprofit partners to help kick off marathon weekend and showcase how employees can volunteer and give.
A group of five smile while posing for a photo outside on Nike's World Headquarter campus; four people are wearing white t-shirts with black lettering that reads, "Give Cancer Hell." while three people are wearing pink running hats.
ohsuknight.bsky.social
"Our 12th annual donor drive is officially in the books, and what a ride it was.

"Each year, we're reminded why we do this work. We meet incredible people and hear inspiring stories of strength, courage, and hope."

- Kathie Phan, oncology nurse and team lead for the registry drive
Group of ten people, all wearing red, standing in front of The Sports Bra, holding up signs encouraging people to register for the 12th annual bone marrow transplant donor drive.
ohsuknight.bsky.social
For the third consecutive year, a new record has been set! 💫

Congrats to our medical team on 14K for registering 366 potential new donors during the 12th annual bone marrow registry drive!

The team held five in-person swabbing events, visited classrooms, and distributed their kits throughout town.
Group of seven people, all wearing red, standing in front of a red DKMS booth on the OHSU campus lawn, registering people for the 12th annual bone marrow transplant donor drive. Group of six people, all wearing red, standing in front of a red DKMS booth outside of an OHSU building, registering people for the 12th annual bone marrow transplant donor drive. Four people smile while wearing red as they stand in front of a red booth next to a sign showcasing how many people have registered to sign up for a bone marrow transplant donor drive. The red sign says, "I Swabbed To Save A Life #DeleteBloodCancer." Group of seven people, all wearing red, standing in front of The Sports Bra, holding up signs encouraging people to register for the 12th annual bone marrow transplant donor drive.
ohsuknight.bsky.social
Share these with a friend, a family member, or a loved one.
A blue graphic with white text reading, "About 92% of U.S. women with breast cancer live at least five years after diagnosis. When cancer is diagnosed before it has spread from the breast, the rate rises to more than 99%." A blue graphic with white text reading, "Breast cancer occurs in one (1) out of every eight (8) women and is the second leading cause of cancer death in women in the United States." A blue graphic with white text reading, "Most cases are found in women and people assigned female at birth who are over 50. But younger women and men can get breast cancer, too. About 2,800 cases a year are diagnosed in men."
ohsuknight.bsky.social
October is Breast Cancer Awareness Month 🩷

Here are 5️⃣ facts to know about breast cancer.
A blue graphic with white text reading, "Breast cancer happens when cells in one or both breasts grow out of control to form tumors. Some tumors are big enough to be felt, but not all breast lumps are cancer. Any breast lump or change should be checked by a health care professional." A blue graphic with white text reading, "About 320,000 cases of breast cancer are diagnosed in women each year in the United States. More than 4 million U.S. women live with or have survived breast cancer."
Reposted by OHSU Knight Cancer Institute
ohsudoernbecher.bsky.social
Our pediatric hematology and oncology teams are going gold this September! 💛 ✨ On #GoGoldDay, you’ll spot us rocking our “Fight Like a Kid 🎗️” shirts — because kids facing cancer show us every day what true strength looks like. @ohsuknight.bsky.social
ohsuknight.bsky.social
#GiveCancerHell mobile wallpapers now available 📲
Black background with white lettering reading, "Give Cancer Hell" along with a white OHSU Knight Cancer Institute logo White background with black lettering reading, "Give Cancer Hell" along with a black OHSU Knight Cancer Institute logo
ohsuknight.bsky.social
“What is impressive about caring for these patients, in addition to their incredible sense of resilience and hope, is how they articulate their prognostic understanding.”

- Dr. Brandon Hayes-Lattin on the resilience and hope in adolescents and young adults with cancer: https://bit.ly/48y8fx9
Portrait of a person smiling; text underneath reads, "Brandon Hayes-Lattin, M.D., FACP" A white OHSU logo is placed in the bottom right-hand corner. The background of the graphic showcases an early morning sunrise with pink and purple skies settling over Mt. Hood.
ohsuknight.bsky.social
“By integrating the Astral with our emerging spatial and single-cell pipelines, we can chart the molecular circuits that drive cancer and other diseases at unprecedented resolution.”

- Dr. Andrew Emili on the Thermo Fisher Orbitrap Astral mass spectrometer: https://bit.ly/3Wa6fUh
Portrait of person smiling; text underneath reads, "Andrew Emili, Ph.D." A white OHSU logo is placed in the bottom right-hand corner. The background of the graphic showcases an early morning sunrise with fog settling over Portland's South Waterfront.
ohsuknight.bsky.social
Join us in sharing the facts about HPV vaccination and increasing the number of children protected today against HPV cancers tomorrow.
ohsuknight.bsky.social
What you can do:
✅ Parents – ask your child’s doctor about HPV vaccination starting at age 9.
✅ Providers – recommend HPV vaccination at every visit.
✅ Communities – spread the word: HPV vaccination is cancer prevention.
ohsuknight.bsky.social
HPV vaccination is safe and protects against six types of cancer – including cervical, oropharyngeal, and anal cancers.

Recent data show no gains in HPV vaccination coverage, falling short of national goals.

We must act now to protect today’s children from future HPV-related cancers.
White and blue graphic with text reading, "HPV vaccination protects against more than 90% of HPV-related cancer. Safe. Effective. Long-lasting protection."
ohsuknight.bsky.social
Dr. Brandon Hayes-Lattin discusses the resilience and hope in adolescents and young adults with advanced cancer.

Learn more (via @ascopost.bsky.social): bit.ly/48y8fx9
Portrait of a person smiling; text underneath reads, "Brandon Hayes-Lattin, M.D., FACP" A white OHSU logo is placed in the bottom right-hand corner. The background of the graphic showcases an early morning sunrise with pink and purple skies settling over Mt. Hood.
ohsuknight.bsky.social
OHSU will bring in a state-of-the-art mass spectrometer thanks to a grant from the M.J. Murdock Charitable Trust.

The new technology, led by Dr. Andrew Emili, will boost our ability to study proteins for early disease detection and precision medicine.

Learn more: https://bit.ly/3Wa6fUh
Portrait of person smiling; text underneath reads, "Andrew Emili, Ph.D." A white OHSU logo is placed in the bottom right-hand corner. The background of the graphic showcases an early morning sunrise with fog settling over Portland's South Waterfront.
ohsuknight.bsky.social
In Warm Springs, Oregon, the love of basketball is uniting a community against #PancreaticCancer.

This aggressive disease disproportionately affects Native American communities, with a grim survival rate.

But a new partnership at OHSU is aiming to change that narrative ⤵️
Warm Springs and OHSU: A New Alliance Against Pancreatic Cancer
The basketball tournament and associated outreach efforts by the OHSU Knight Cancer Institute's Community Outreach and Engagement (COE) program and the Brenden-Colson Center for Pancreatic Care in War...
now.ohsu.edu
ohsuknight.bsky.social
Join us for this year’s Early Detection of Cancer conference!

🗓️ Oct. 21-23
📍Portland, OR
🤝 @cancerresearchuk.org, Canary Center at Stanford

The conference will be packed with discussions, lightning talks from submitted abstracts, and networking opportunities.

Register ⤵️
HOME
The Early Detection of Cancer Conference brings together experts in early detection from multiple disciplines to share ground breaking research and progress in the field.
bit.ly
ohsuknight.bsky.social
September is Prostate Cancer Awareness Month 🩵

Here are 4️⃣ facts to know about #ProstateCancer.

Share these with a friend, a family member, or a loved one.
ohsuknight.bsky.social
Dr. Alexandra Sokolova discusses the TRIPLE-SWITCH trial, a study that addresses treatment intensification in metastatic hormone-sensitive #ProstateCancer.

Watch (via Urology Today): https://bit.ly/41Cekoc
Screenshot of a video interview featuring Dr. Alexandra Sokolova smiling. Text above the screenshot reads, "TRIPLE-SWITCH Trial Tests Docetaxel Addition for mHSPC Patients with Suboptimal PSA Response - Alexandra Sokolova"
ohsuknight.bsky.social
Dr. Alexandra Sokolova discusses the TRIPLE-SWITCH trial, a study that addresses treatment intensification in metastatic hormone-sensitive #ProstateCancer.

Watch (via Urology Today): https://bit.ly/41Cekoc
Screenshot of a video interview featuring Dr. Alexandra Sokolova smiling. Text above the screenshot reads, "TRIPLE-SWITCH Trial Tests Docetaxel Addition for mHSPC Patients with Suboptimal PSA Response - Alexandra Sokolova"
ohsuknight.bsky.social
Dr. Alexandra Sokolova discusses the TRIPLE-SWITCH trial, a study that addresses treatment intensification in metastatic hormone-sensitive #ProstateCancer.

Watch (via Urology Today): https://bit.ly/41Cekoc
Screenshot of a video interview featuring Dr. Alexandra Sokolova smiling. Text above the screenshot reads, "TRIPLE-SWITCH Trial Tests Docetaxel Addition for mHSPC Patients with Suboptimal PSA Response - Alexandra Sokolova"